U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 196

1.
A potential defensive role of TIM-3 on T lymphocytes in the inflammatory involvement of diabetic kidney disease
Xiao-Jun Chen, Runyan Tang, Jie Zha, Li Zeng, Linshan Zhou, Zhiwen Liu, Danyi Yang, Mengru Zeng, Xuejing Zhu, Anqun Chen, Hong Liu, Huihui Chen, Guochun Chen
Front Immunol. 2024; 15: 1365226. Published online 2024 May 15. doi: 10.3389/fimmu.2024.1365226
PMCID:
PMC11133625
AbstractArticlePDF–18M
2.
Association of tuberculosis risk with genetic polymorphisms of the immune checkpoint genes PDCD1, CTLA-4, and TIM3
Chi-Wei Liu, Lawrence Shih-Hsin Wu, Chou-Jui Lin, Hsing-Chu Wu, Kuei-Chi Liu, Shih-Wei Lee
PLoS One. 2024; 19(5): e0303431. Published online 2024 May 9. doi: 10.1371/journal.pone.0303431
PMCID:
PMC11081348
AbstractArticlePDF–862K
3.
Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer
Bangwei Cao, Linzhong Zhu, Shengtao Zhu, Danping Li, Chuanzhen Zhang, Changqing Xu, Shutian Zhang
Cancer Immunol Immunother. 2010 Dec; 59(12): 1851–1857. Published online 2010 Sep 2. doi: 10.1007/s00262-010-0910-5
PMCID:
PMC11030773
AbstractArticlePDF–218K
4.
The role of TIM-3 in sepsis: a promising target for immunotherapy?
Changli Wang, Jinhai Liu, Qi Wu, Zhi Wang, Baoji Hu, Lulong Bo
Front Immunol. 2024; 15: 1328667. Published online 2024 Mar 21. doi: 10.3389/fimmu.2024.1328667
PMCID:
PMC10991702
AbstractArticlePDF–1.2M
5.
Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia
Shuxin Huang, Yujie Zhao, Wenpu Lai, Jiaxiong Tan, Xue Zheng, Xianfeng Zha, Yangqiu Li, Shaohua Chen
Cancer Biol Ther. 2023; 24(1): 2278229. Published online 2023 Nov 14. doi: 10.1080/15384047.2023.2278229
PMCID:
PMC10903599
AbstractArticlePDF–4.9M
6.
Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway
Qiqi Zhu, Yiming Yang, Kexin Chen, Qiaoyu Zhang, Yifan Huang, Shunhai Jian
J Transl Med. 2024; 22: 174. Published online 2024 Feb 18. doi: 10.1186/s12967-024-05002-3
PMCID:
PMC10874540
AbstractArticlePDF–5.7M
7.
The balance between CD4+ T helper 17 and T-cell immunoglobulin and mucin domain 3 is involved in the pathogenesis and development of atrial fibrillation
Wenjing Dai, Jun Zhang, Yang Wang, Jingqun Zhou, Qiuting Dai, Jianfeng Lv
Afr Health Sci. 2023 Sep; 23(3): 607–615. doi: 10.4314/ahs.v23i3.71
PMCID:
PMC10862566
AbstractArticlePDF–322K
8.
TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1
Hooriyeh Shapourian, Mustafa Ghanadian, Nahid Eskandari, Abolfazl Shokouhi, Gülderen Yanikkaya Demirel, Alexandr V. Bazhin, Mazdak Ganjalikhani-Hakemi
BMC Cancer. 2024; 24: 125. Published online 2024 Jan 24. doi: 10.1186/s12885-024-11898-3
PMCID:
PMC10809689
AbstractArticlePDF–3.6M
9.
Expression of B7‐H3 and TIM‐3 in gastric‐type endocervical adenocarcinoma: prevalence, association with PD‐L1 expression, and prognostic significance
Yao Sun, Xin Zhou, Elena Lucas, Lili Chen, Huijuan Zhang, Hao Chen, Feng Zhou
J Pathol Clin Res. 2024 Jan; 10(1): e345. Published online 2023 Oct 5. doi: 10.1002/cjp2.345
PMCID:
PMC10766062
AbstractArticlePDF–1.3M
10.
Case Report: HAVCR2 mutation-associated Hemophagocytic lymphohistiocytosis
Deli Song, Jingshi Wang, Jia Zhang, Junxia Hu, Chaofan Wu, Zhao Wang
Front Immunol. 2023; 14: 1271324. Published online 2023 Nov 23. doi: 10.3389/fimmu.2023.1271324
PMCID:
PMC10701531
AbstractArticlePDF–1.2M
11.
TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
Mahnaz Rezaei, Mustafa Ghanadian, Behrooz Ghezelbash, Abolfazl Shokouhi, Alexandr V. Bazhin, Andrey A. Zamyatnin, Jr., Mazdak Ganjalikhani-Hakemi
Front Immunol. 2023; 14: 1267578. Published online 2023 Nov 10. doi: 10.3389/fimmu.2023.1267578
PMCID:
PMC10667689
AbstractArticlePDF–2.0M
12.
Tim-3 Is Differentially Expressed during Cell Activation and Interacts with the LSP-1 Protein in Human Macrophages
Ranferi Ocaña-Guzman, Lucero A. Ramon-Luing, Luis A. Vazquez-Bolaños, Michelle Rodríguez-Alvarado, Fausi Bulhusen-Rodriguez, Alonso Torres-Hatem, Karen Gonzalez-Torres, Mariana Citlalli de Alba-Alvarado, Isabel Sada-Ovalle
J Immunol Res. 2023; 2023: 3577334. Published online 2023 Oct 26. doi: 10.1155/2023/3577334
PMCID:
PMC10622183
AbstractArticlePDF–717K
13.
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Natalia Sauer, Natalia Janicka, Wojciech Szlasa, Bartłomiej Skinderowicz, Katarzyna Kołodzińska, Wioletta Dwernicka, Małgorzata Oślizło, Julita Kulbacka, Vitalij Novickij, Katarzyna Karłowicz-Bodalska
Cancer Immunol Immunother. 2023 Nov; 72(11): 3405–3425. Published online 2023 Aug 11. doi: 10.1007/s00262-023-03516-1
PMCID:
PMC10576709
AbstractArticlePDF–1.5M
14.
Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer
Xing He, Yaorong Peng, Gui He, Huilin Ye, Liqiang Liu, Qixian Zhou, Juanyi Shi, Sha Fu, Jie Wang, Zhenyu Zhou, Wenbin Li
J Transl Med. 2023; 21: 717. Published online 2023 Oct 12. doi: 10.1186/s12967-023-04589-3
Correction in:
J Transl Med. 2024; 22: 118.
PMCID:
PMC10571407
AbstractArticlePDF–4.6M
15.
Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis
Chatphatai Moonla, Chantana Polprasert, Patcharee Komvilaisak, Thanawat Rattanathammethee, Sunisa Kongkiatkamon, Kitsada Wudhikarn, Sirorat Kobbuaklee, Pitchayut Boonyabaramee, Nuanrat Tangcheewinsirikul, Samart Pakakasama, Piya Rujkijyanont, Chane Choed-Amphai, Kamon Phuakpet, Saranya Pongudom, Udomsak Bunworasate, Narittee Sukswai, Darintr Sosothikul, Ponlapat Rojnuckarin
Haematologica. 2023 Oct 1; 108(10): 2743–2752. Published online 2023 Apr 13. doi: 10.3324/haematol.2022.282419
PMCID:
PMC10543163
AbstractArticlePDF–1.5M
16.
Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma
Nafeesa Moksud, Marta Wagner, Konrad Pawełczyk, Irena Porębska, Beata Muszczyńska-Bernhard, Aneta Kowal, Andrzej Wiśniewski, Monika Kosacka, Julia Kończak, Paweł Karpiński, Dominik Frydryk, Anna Andrzejczak, Lidia Karabon, Piotr Kuśnierczyk, Monika Jasek
J Cancer Res Clin Oncol. 2023; 149(9): 6381–6390. Published online 2023 Feb 9. doi: 10.1007/s00432-023-04602-8
PMCID:
PMC10356891
AbstractArticlePDF–800K
17.
TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia
Teppei Sakoda, Yoshikane Kikushige, Toshihiro Miyamoto, Hidetoshi Irifune, Takuya Harada, Kiwamu Hatakeyama, Yuya Kunisaki, Koji Kato, Koichi Akashi
Blood Adv. 2023 May 23; 7(10): 2053–2065. Published online 2023 Feb 8. doi: 10.1182/bloodadvances.2022008405
PMCID:
PMC10196803
AbstractArticlePDF–1.9M
18.
Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
Zhengwei Wu, Jiawang Ou, Nannan Liu, Zhixiang Wang, Junjie Chen, Zihong Cai, Xiaoli Liu, Xiao Yu, Min Dai, Hongsheng Zhou
Cancer Med. 2023 Apr; 12(7): 8956–8969. Published online 2022 Dec 21. doi: 10.1002/cam4.5549
PMCID:
PMC10134367
AbstractArticlePDF–11M
19.
A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases
Vigdis Nygaard, Anne Hansen Ree, Vegar Johansen Dagenborg, Anne-Lise Børresen-Dale, Bjørn Edwin, Åsmund Avdem Fretland, Krzysztof Grzyb, Mads H. Haugen, Gunhild M. Mælandsmo, Kjersti Flatmark
Cancer Res Commun. 2023 Feb; 3(2): 235–244. Published online 2023 Feb 9. doi: 10.1158/2767-9764.CRC-22-0295
PMCID:
PMC10035516
AbstractArticlePDF–5.7M
20.
Characterization of TIM-3 Expression and Its Correlation with TNF-α and IFN-γ in Patients with Surgically Resected Lung Adenocarcinoma
Jian Tan, Piao Shen, Xingping Yang, Weijie Cai, Hongying Liao
Dis Markers. 2023; 2023: 2352945. Published online 2023 Feb 21. doi: 10.1155/2023/2352945
PMCID:
PMC9974258
AbstractArticlePDF–912K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center